Zencogen is a preclinical stage biotech company developing breakthrough antibody based therapies to improve patient outcomes in oncologic diseases. Zencogen is the foremost biotech targeting phosphatases for treating late stage cancers, with a pipeline of humanized and highly specific antibodies deployed through RDC and ADC. Zencogen is based both in the US and China.
Address
ShanghaiChina
